Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studiesBMJ 2006; 332 doi: https://doi.org/10.1136/bmj.38678.389583.7C (Published 12 January 2006) Cite this as: BMJ 2006;332:73
- Rachel Huxley, senior epidemiologist ()1,
- Federica Barzi, senior research fellow1,
- Mark Woodward, professor of biostatistics1
- 1 George Institute for International Health, University of Sydney, PO Box M201, Sydney, NSW 2050, Australia
- Correspondence to: R Huxley
- Accepted 8 November 2005
Objective To estimate the relative risk for fatal coronary heart disease associated with diabetes in men and women.
Design Meta-analysis of prospective cohort studies.
Data sources Studies published between 1966 and March 2005, identified through Embase and Medline, using a combined text word and MESH heading search strategy, in addition to studies from the Asia Pacific Cohort Studies Collaboration.
Review methods Studies were eligible if they had reported estimates of the relative risk for fatal coronary heart disease comparing men and women with and without diabetes. Studies were excluded if the estimates were not adjusted at least for age.
Results 37 studies of type 2 diabetes and fatal coronary heart disease among a total of 447 064 patients were identified. The rate of fatal coronary heart disease was higher in patients with diabetes than in those without (5.4 v 1.6%). The overall summary relative risk for fatal coronary heart disease in patients with diabetes compared with no diabetes was significantly greater among women than it was among men: 3.50, 95% confidence interval 2.70 to 4.53 v 2.06, 1.81 to 2.34. After exclusion of the eight studies that had adjusted only for age, the difference in risk between the sexes was substantially reduced but still highly significant. The pooled ratio of the relative risks (women: men) from the 29 studies with multiple adjusted estimates was 1.46 (1.14 to 1.88).
Conclusions The relative risk for fatal coronary heart disease associated with diabetes is 50% higher in women than it is in men. This greater excess coronary risk may be explained by more adverse cardiovascular risk profiles among women with diabetes, combined with possible disparities in treatment that favour men.
Web references w1-w46, additional figures, and details of studies contributing data are on bmj.com
Contributors All authors contributed to the interpretation of the analyses and drafting the manuscript. RH is guarantor.
Funding RH is supported by a University of Sydney Sesqui postdoctoral fellowship. This work has received funds from the Australian National Health and Medical Research Council and from an unconditional educational grant from Pfizer.
Competing interests None declared.
Ethical approval Not required.